Key result
The COVID-19 outbreak is linked to a ~35% reduction in STEMI admissions versus previous years.
Why the study?
Public health emergencies like COVID-19 may impact STEMI incidence rates, but this phenomenon required evaluation in areas where the healthcare system was not overwhelmed.
Does the COVID-19 outbreak reduce the incidence rate of STEMI admissions?
Observational
No
Does the COVID-19 outbreak reduce the incidence rate of STEMI admissions?
Relative Risk: 0.65 (95% CI 0.42–0.96)
Absolute Event Rate: 36% vs 56%
p-value: p=0.045
The COVID-19 pandemic was associated with a significant decrease in STEMI admissions and a higher proportion of patients presenting with heart failure, suggesting avoidance of medical care.
May signal care avoidance during outbreaks; leaves open true STEMI incidence and requires prospective validation.
BACKGROUND: Public health emergencies such as the COVID-19 outbreak may impact on the incidence rate of ST-elevation myocardial infarction (STEMI) in severely affected areas. However, this phenomenon demands attention also in areas where media and patients were focused on the COVID-19 pandemic, but the healthcare system was not overwhelmed by the huge number of COVID-19 patients. METHODS AND RESULTS: In this observational study, we compared the incidence rate of all consecutive STEMI patients admitted at the University Hospital of Trieste, Italy, during March and April 2020 with the same 2 months of the previous 5 years (2015-2019). Patient characteristics were compared between 2020 and 2019.The incidence rate of STEMI admission in March-April 2020 was lower than those in March-April 2015-2019, 36 vs. 56 cases per 100 000 inhabitants/year [relative risk (RR) 0.65, 95% confidence interval (95% CI) 0.42-0.96, P = 0.045]. Considering that the incidence rates were constant in the past years (P = 0.24), the turnaround in 2020 is most likely due to the COVID-19 outbreak. Interestingly, this reduction was a dynamic phenomenon with a U-shaped curve during the 2-month period. System-of-care times were similar between 2020 and 2019; however in 2020, patients presented more frequently signs of heart failure compared to 2019 (Killip class ≥2 in 68% vs. 29%, P = 0.003). CONCLUSION: During the COVID-19 outbreak, we observed a marked reduction in the STEMI incidence rate. This U-shaped phenomenon demands attention because a potential cause for the decrease in STEMI incidence may include the avoidance of medical care. Public campaigns aiming to increase awareness of ischemic symptoms may be needed during community outbreak.
No takes yet. Share an insight, caveat, or question.
Fabris et al. (2021) conducted an observational in ST-elevation myocardial infarction (STEMI). COVID-19 outbreak (March-April 2020) vs. March-April 2015-2019 was evaluated on Incidence rate of STEMI admission (RR 0.65, 95% CI 0.42-0.96, p=0.045). The COVID-19 outbreak in March-April 2020 was associated with a lower incidence rate of STEMI admissions compared to 2015-2019 (36 vs. 56 cases per 100,000/year; RR 0.65; 95% CI 0.42-0.96; P=0.045).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: